Home › Funds › Pale Fire Capital SE › CRBP
Pale Fire Capital SE position in CRBP
CORBUS PHARMACEUTICALS HLDGS · Health Care
Pale Fire Capital SE reported holding 27,300 shares of CRBP (CORBUS PHARMACEUTICALS HLDGS) in its Q3 2026 13F filing — a position valued at US$186K, representing 0.01% of its reported portfolio and ranking #49 among its reported holdings. Pale Fire Capital SE has disclosed CRBP holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Pale Fire Capital SE's CRBP position evolved
Pale Fire Capital SE first disclosed a stake in CRBP in Q4 2025 at 18,650 shares (US$152K). The position peaked in Q2 2026 at 24,301 shares, worth US$228K. Across 4 filings, Pale Fire Capital SE increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 27,300 shares valued at US$186K — an increase of 2,999 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 18.65K | $151.81K | New |
| Q1 2026 | 21.35K | $200.48K | Add |
| Q2 2026 | 24.30K | $227.94K | Add |
| Q3 2026 | 27.30K | $186.19K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CRBP and 13F data
CRBP (CORBUS PHARMACEUTICALS HLDGS) is a Health Care company. 21 other funds we track also report a position in CRBP — the largest reported positions include Cormorant Asset Management, LP (US$22.0M), Jones Hill Capital LP (US$6.0M), DIADEMA PARTNERS LP (US$2.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CRBP
- Cormorant Asset Management, LP 2.34M sh · $22.00M · Q2 2026
- Jones Hill Capital LP 886.43K sh · $6.05M · Q3 2026
- DIADEMA PARTNERS LP 301.26K sh · $2.83M · Q2 2026
- Exome Asset Management LLC 184.91K sh · $1.73M · Q2 2026
- Prosight Management, LP 168.38K sh · $1.15M · Q3 2026
More on Pale Fire Capital SE
FAQ
How long has Pale Fire Capital SE held CRBP?
Pale Fire Capital SE has disclosed CRBP holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Pale Fire Capital SE's current position in CRBP?
As of Q3 2026, Pale Fire Capital SE holds 27.30K shares of CRBP (CORBUS PHARMACEUTICALS HLDGS), valued at $186.19K, representing 0.01% of its reported portfolio and ranking #49.
Has Pale Fire Capital SE been buying or selling CRBP?
In the latest 13F filing (Q3 2026), Pale Fire Capital SE increased its position in CRBP. The position peaked in Q2 2026 at 24.30K shares.
Which other funds hold CRBP?
Other major institutional holders of CRBP include Cormorant Asset Management, LP, Jones Hill Capital LP, DIADEMA PARTNERS LP, among 21 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.